Ayushi Gupta

XSOLIS is a platform, data science and solutions innovator serving health plans, hospitals and payer organizations nationwide to create a more efficient healthcare system. Through its purpose-built solutions and industry-leading AI, XSOLIS breaks down healthcare silos to accelerate data-driven decision making and collaboration across a connected network of providers and payers. CORTEX®, its AI-driven technology platform, is the first and only solution to use real-time predictive analytics to continuously assign an objective medical necessity score and assess the anticipated level of care for every patient. CORTEX eliminates waste through the science of data using automation, transparency and objective insights to ensure appropriate care settings, enabling more efficiency across the healthcare system. XSOLIS is headquartered in Nashville, Tennessee. Our Values - Team First - Client Passionate - Always Curious - Deliver Excellence XSOLIS recently ranked No. 1795 on the 2022 Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America, and was named 2022 Best in Business among private companies by the Nashville Business Journal. XSOLIS executives have been featured in Beckers Hospital Review, Beckers Payer Issues, Chief Healthcare Executive, CIO Review, Managed Healthcare Executive, Healthcare IT Today, among other leading publications. For more information, visit www.xsolis.com.

Brighton Park is an investment firm that specializes in software, information services, and technology-enabled services. We partner with exceptional management teams and use our decades of operating experience to help them build world class companies. We help our companies attract unique talent, develop market-leading products, build highly productive sales organizations, and connect better with customers through the use of technology.

Lumanity applies incisive thinking and decisive action to cut through complex situations and deliver transformative outcomes to accelerate and optimize access to medical advances. With deep experience in medical, commercial, and regulatory affairs, Lumanity transforms data and information into real-world insights and evidence that powers successful commercialization and empowers patients, providers, payers, and regulators to take timely and decisive action.

Redesign Health is a global venture and applied technology firm focused on building next-generation healthcare companies. We manage venture capital and venture buyout strategies, each powered by an AI operating system and team of leading technologists, entrepreneurs, and investors. Our venture capital strategy backs exceptional founders at the earliest stage—often before an idea is fully formed—and provides first institutional capital and an unmatched degree of strategic leverage and domain expertise through exit. Our venture buyout strategy partners with proven management teams through control investments and delivers outsized value by rewiring core products and workflows with AI. Since inception in 2018, Redesign and our portfolio companies have touched the lives of more than 15 million patients, raised over $1.5 billion from premier institutional, sovereign, and strategic investors, and built distinctive partnerships with marquee healthcare organizations and senior leaders around the world. Redesign is based in New York and has offices in Bengaluru, Los Angeles, and Riyadh.

XSOLIS is a platform, data science and solutions innovator serving health plans, hospitals and payer organizations nationwide to create a more efficient healthcare system. Through its purpose-built solutions and industry-leading AI, XSOLIS breaks down healthcare silos to accelerate data-driven decision making and collaboration across a connected network of providers and payers. CORTEX®, its AI-driven technology platform, is the first and only solution to use real-time predictive analytics to continuously assign an objective medical necessity score and assess the anticipated level of care for every patient. CORTEX eliminates waste through the science of data using automation, transparency and objective insights to ensure appropriate care settings, enabling more efficiency across the healthcare system. XSOLIS is headquartered in Nashville, Tennessee. Our Values - Team First - Client Passionate - Always Curious - Deliver Excellence XSOLIS recently ranked No. 1795 on the 2022 Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America, and was named 2022 Best in Business among private companies by the Nashville Business Journal. XSOLIS executives have been featured in Beckers Hospital Review, Beckers Payer Issues, Chief Healthcare Executive, CIO Review, Managed Healthcare Executive, Healthcare IT Today, among other leading publications. For more information, visit www.xsolis.com.

Brighton Park is an investment firm that specializes in software, information services, and technology-enabled services. We partner with exceptional management teams and use our decades of operating experience to help them build world class companies. We help our companies attract unique talent, develop market-leading products, build highly productive sales organizations, and connect better with customers through the use of technology.

OncoHealth is a leading digital health company dedicated to helping health plans, employers, providers, patients, and researchers navigate the physical, mental and financial complexities of cancer through technology-enabled services and real-world data analytics. Supporting more than 12 million people in the US and Puerto Rico, OncoHealth offers digital solutions for treatment review, real-world evidence, and virtual care across all cancer types. For more information, visit www.oncohealth.us

Lumanity applies incisive thinking and decisive action to cut through complex situations and deliver transformative outcomes to accelerate and optimize access to medical advances. With deep experience in medical, commercial, and regulatory affairs, Lumanity transforms data and information into real-world insights and evidence that powers successful commercialization and empowers patients, providers, payers, and regulators to take timely and decisive action.